Which company announced a partnership in 2022 to develop mRNA-based vaccines for

₹0.0

Question: Which company announced a partnership in 2022 to develop mRNA-based vaccines for infectious diseases?

Options:

Correct Answer: Moderna and Merck

Solution:

In 2022, Moderna announced a partnership with Merck to develop mRNA-based vaccines targeting various infectious diseases.

Which company announced a partnership in 2022 to develop mRNA-based vaccines for infectious diseases?

Which company announced a partnership in 2022 to develop mRNA-based vaccines for infectious diseases?

Step 1: Identify the year mentioned in the question, which is 2022.
Step 2: Look for companies that announced partnerships in that year.
Step 3: Find out which companies are known for developing mRNA-based vaccines.
Step 4: Confirm that Moderna is one of the companies that develops mRNA vaccines.
Step 5: Check if Moderna announced a partnership in 2022.
Step 6: Verify that Moderna partnered with Merck for this purpose.
Step 7: Conclude that the partnership was to develop mRNA-based vaccines for infectious diseases.

No concepts available.